Atossa Therapeutics, Inc.

NasdaqCM:ATOS Stock Report

Market Cap: US$129.6m

Atossa Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:ATOS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Apr 24BuyUS$44,250Jonathan FinnIndividual25,000US$1.77

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ATOS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies22,2540.0177%
Individual Insiders51,1580.0407%
VC/PE Firms7,762,5006.17%
Institutions27,709,67522%
General Public90,255,66771.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 27.1% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.68%
BlackRock, Inc.
9,667,615US$10.0m5.12%no data
6.17%
Heights Capital Management, Inc.
7,762,500US$8.0m0%1.33%
5.25%
The Vanguard Group, Inc.
6,598,296US$6.8m1.73%no data
2.24%
Geode Capital Management, LLC
2,814,446US$2.9m1.62%no data
1.38%
State Street Global Advisors, Inc.
1,732,221US$1.8m4.16%no data
1.04%
Renaissance Technologies LLC
1,310,070US$1.3m-15.5%no data
0.76%
Northern Trust Global Investments
954,199US$982.8k257%no data
0.36%
Morgan Stanley, Investment Banking and Brokerage Investments
446,772US$460.2k3.45%no data
0.28%
Charles Schwab Investment Management, Inc.
347,610US$358.0k-6.05%no data
0.24%
BNY Asset Management
303,649US$312.8k-26.2%no data
0.2%
Gescooperativo S.A. SGIIC
250,398US$257.9k0%0.02%
0.2%
Goldman Sachs Group, Investment Banking and Securities Investments
249,128US$256.6k143%no data
0.16%
Connor, Clark & Lunn Investment Management Ltd.
199,754US$205.8k-4.53%no data
0.16%
Qube Research & Technologies Ltd
195,589US$201.5k24.2%no data
0.14%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
170,733US$175.9k0%no data
0.13%
Barclays PLC Private Banking & Investment Banking Investment
167,718US$172.7k281%no data
0.13%
Citadel Advisors LLC
161,899US$166.8k-19.6%no data
0.11%
Jane Street Group, LLC, Asset Management Arm
136,935US$141.0k-47.4%no data
0.098%
Rhumbline Advisers Ltd Partnership
123,039US$126.7k-8.94%no data
0.076%
Two Sigma Investments, LP
96,223US$99.1k-47.4%no data
0.075%
JPMorgan Chase & Co, Brokerage and Securities Investments
94,721US$97.6k101,000%no data
0.073%
Citigroup Inc.,Banking and Securities Investments
91,977US$94.7k73%no data
0.057%
Bank of America Corporation, Asset Management Arm
71,866US$74.0k-30.8%no data
0.057%
Susquehanna International Group, LLP, Asset Management Arm
71,772US$73.9k0%no data
0.056%
UBS Asset Management AG
70,793US$72.9k70.8%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 06:46
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Atossa Therapeutics, Inc. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Louise ChenCantor Fitzgerald & Co.
Pooya HemamiEdison Investment Research